Spectroscopic identification of an amorphous-to-crystalline drug transition in a solid dispersion SCH 48461 capsule formulation.
about
Determination of indomethacin crystallinity in the presence of excipients using diffuse reflectance near-infrared spectroscopy.19F solid-state NMR spectroscopic investigation of crystalline and amorphous forms of a selective muscarinic M3 receptor antagonist, in both bulk and pharmaceutical dosage form samples.Solid‐State NMR Studies of Pharmaceutical Systems
P2860
Spectroscopic identification of an amorphous-to-crystalline drug transition in a solid dispersion SCH 48461 capsule formulation.
description
1997 nî lūn-bûn
@nan
1997 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Spectroscopic identification o ...... SCH 48461 capsule formulation.
@ast
Spectroscopic identification o ...... SCH 48461 capsule formulation.
@en
type
label
Spectroscopic identification o ...... SCH 48461 capsule formulation.
@ast
Spectroscopic identification o ...... SCH 48461 capsule formulation.
@en
prefLabel
Spectroscopic identification o ...... SCH 48461 capsule formulation.
@ast
Spectroscopic identification o ...... SCH 48461 capsule formulation.
@en
P2093
P1476
Spectroscopic identification o ...... SCH 48461 capsule formulation.
@en
P2093
Coscolluela CB
Markovich RJ
P304
P356
10.1016/S0731-7085(97)00083-6
P577
1997-12-01T00:00:00Z